D

DNLI

Denali Therapeutics Inc

24.40

Aug 14 • 3:59 PM ET -0.42 (-1.69%)

24.56

Aftermarket • 7:34 PM ET +0.16 (0.66%)

Healthcare Biotechnology USA Mid NASD

Peers: ACAD XENE AXSM BMRN VKTX INCY NBIX MDGL KROS BIIB

| Held by: VTI IWM XBI VB VBK VXF IWN TCAF IBB VTWO

Scroll to Statements

Index	RUT
Market Cap	3.90B
Enterprise Value	3.23B
Income	-511.45M
Sales	3.60M
Book/sh	5.23
Cash/sh	4.44
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	503
IPO	Dec 08, 2017

P/E	-
Forward P/E	-
PEG	-
P/S	1083.41
P/B	4.67
P/C	5.49
P/FCF	-
EV/EBITDA	-
EV/Sales	896.53
Quick Ratio	8.32
Current Ratio	8.37
Debt/Eq	0.05
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-2.84
EPS next Y	-2.34
EPS next Q	-0.39
EPS this Y	23.23%
EPS next Y	-2.43%
EPS next 5Y	14.79%
EPS past 3/5Y	-4.56% -
Sales past 3/5Y	- -
EPS Y/Y TTM	-1.07%
Sales Y/Y TTM	-100.00%
EPS Q/Q	5.93%
Sales Q/Q	-
Earnings	Aug 06 AMC
EPS/Sales Surpr.	-32.55% 67.29%

Insider Own	6.30%
Insider Trans	-0.03%
Inst Own	97.85%
Inst Trans	0.72%
ROA	-44.01%
ROE	-54.93%
ROIC	-59.29%
Gross Margin	-318.04%
Oper. Margin	-15058.19%
Profit Margin	-14191.20%
SMA20	1.41%
SMA50	2.30%
SMA200	20.50%
Trades

Shs Outstand	159.76M
Shs Float	149.78M
Short Float	11.64%
Short Ratio	9.51
Short Interest	17.43M
52W High	27.30 -10.62%
52W Low	12.58 93.96%
Volatility	3.28% 3.93%
ATR (14)	1.02
RSI (14)	51.63
Beta	1.02
Rel Volume	0.49
Avg Volume	1.83M
Volume	889,995

Perf Week	-1.73%
Perf Month	7.35%
Perf Quarter	25.84%
Perf Half Y	27.22%
Perf YTD	47.79%
Perf Year	68.74%
Perf 3Y	-0.12%
Perf 5Y	-53.73%
Perf 10Y	-
Recom	1.15
Target Price	35.44
Prev Close	24.82
Price	24.40
Change %	-1.69%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)